期刊文献+

HOMA法和血糖钳夹法胰岛素抵抗指数的关系 被引量:35

Correlation Between the Homeostasis Model Assessment and the Glucose Clamp in Chinese Type 2 Diabetic Patients
暂未订购
导出
摘要 目的评价HOMA法胰岛素抵抗指数 (HOMA -IR)是否适合于中国 2型糖尿病胰岛素抵抗的临床应用。 方法同步采用HOMA法和血糖钳夹试验对 48例 2型糖尿病人的胰岛素抵抗进行相关分析。 结果HOMA -IR与血糖钳夹试验的胰岛素抵抗指数 (clamp -IR)明显相关 ,经对数转化的二者之间具有更强的相关关系。在亚组分析中 ,对数化的HOMA -IR与clamp -IR在非肥胖和肥胖组、男性和女性组、正常血压和高血压组、饮食疗法和药物治疗组之间均有类似的明显相关关系。经多元回归分析 ,对数化的HOMA -IR是所有与胰岛素抵抗相关的临床指标中最强的相关指数。 结论HOMA -IR适合于中国 2型糖尿病的临床应用。 Objective To evaluate whether the homeostasis model assessment(HOMA) is a reliable index in Chinese type 2 diabetic patients. Methods In the present study, we compared insulin resistance index as assessed by the 2-h glucose clamp test with HOMA in 48 type 2 diabetic patients. Results HOMA-IR significantly correlated clamp insulin resistance index (clamp-IR). The logarithmic transformed HOMA-IR correlated more strongly with logarithmic transformed clamp-IR than did HOMA-IR. The degree of correlation between log HOMA-IR and log clamp-IR was very similar between the lean (BMI<25kg/m 2) and obese subjects, men and women, normal tensive and hypertensive subjects, diet ary and oral hyperglycemic agent intake subjects. In multiple regression analyses, log HOMA-IR was shown to be the strongest contributor to clamp-IR among the clinical variables. Conclusion HOMA-IR strongly correlated with clamp-IR in Chinese type 2 diabetic patients. It can be reliably used in clinical practice.
出处 《上海第二医科大学学报》 CSCD 2002年第4期325-326,330,共3页 Acta Universitatis Medicinalis Secondae Shanghai
基金 上海市卫生局课题 (9942 7)
关键词 HOMA-胰岛素抵抗指数 血糖钳夹胰岛素抵抗指数 对数转化 2型糖尿病 HOMA-IR clamp-IR logarithmic transformation type 2 diabetes
  • 相关文献

参考文献9

  • 1[1]Kirsten AM, Sheila MW, Jim IM, et al. Diagnosing insulin resistance in the general population[J]. Diabetes Care, 2001,24:460-464.
  • 2[2]Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity[J]. Diabetes Care, 2000,23:57-63.
  • 3[3]Emoto M, Nishizawa K, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas[J]. Diabetes Care, 1999,22:818-822.
  • 4[4]Eatthewe OR, Hosker JR, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man[J]. Diabetologgia, 1985,28:412-419.
  • 5[5]Yue TL, Chen J, Bao W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone[J]. Circulation, 2001, 104(21): 2588-2594.
  • 6[6]Mather KJ, Hunt AJ, Steinberg HO, et al. Repeatability characte_ ristics of simple indices of insulin resistance: implications for research applications[J]. J Clin Endocrinol Metab, 2001,86:5457-5464.
  • 7[7]Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension[J]. Am J Hypertens, 2001, 14(1): 51-53.
  • 8[8]Taverna MJ, Pacher N,Bruzzo F, et al. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in type 2 diabetes[J]. Diabet Med, 2001,18(7):584-587.
  • 9[9]Akira K, Yasuhiro S, Esteban CG, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes[J]. Diabetes Care, 2001,24:362-365.

同被引文献295

引证文献35

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部